Inactive Instrument

MDxHealth SA Stock price Euronext Bruxelles

Equities

MDXH

BE0974461940

Biotechnology & Medical Research

Sales 2023 64.39M 69.37M Sales 2024 * 73.13M 78.79M Capitalization 65.43M 70.5M
Net income 2023 -39M -42.02M Net income 2024 * -26M -28.01M EV / Sales 2023 1.51 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 0.89 x
P/E ratio 2023
-2.37 x
P/E ratio 2024 *
-2.58 x
Employees 255
Yield 2023 *
-
Yield 2024 *
-
Free-Float 97.37%
More Fundamentals * Assessed data
Dynamic Chart
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock MDxHealth SA
  4. Stock MDxHealth SA - Euronext Bruxelles